Potassium hydrogen DL-aspartate
CAS: 923-09-1
Ref. 3D-FP159927
| 1kg | A consultar | ||
| 2kg | A consultar | ||
| 5kg | A consultar | ||
| 250g | A consultar | ||
| 500g | A consultar |
Información del producto
- <span class="text-smallcaps">DL</span>-Aspartic acid, monopotassium salt
- Aspartic acid, monopotassium salt
- Aspartic acid, monopotassium salt, <span class="text-smallcaps">DL</span>-
- Aspartic acid, potassium salt (1:1)
- DL-Aspartic acid, potassium salt
- Monopotassium <span class="text-smallcaps">DL</span>-aspartate
- Potassium DL-aspartate
- potassium (2S)-2-aminobutanedioate
Potassium hydrogen DL-aspartate is a form of aspartate that contains potassium. It is used in pharmaceutical preparations for the treatment of inflammatory diseases, such as rheumatoid arthritis and osteoarthritis. Potassium hydrogen DL-aspartate has been shown to have an anti-inflammatory effect by inhibiting phosphodiesterase activity, which reduces the production of prostaglandins. The drug also has a beneficial effect on cardiac function by increasing fatty acid oxidation and reducing lipolysis in ventricular myocytes. This drug is not active against paramyxoviruses or women with sarcoplasmic myopathy.
Propiedades químicas
Consulta técnica sobre: 3D-FP159927 Potassium hydrogen DL-aspartate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
